Daebongls Co Ltd
078140
Company Profile
Business description
Daebongls Co Ltd is a South Korea-based company that engages in the manufacturing and selling of raw pharmaceutical products, cosmetic materials, and food additive raw materials with cost and quality competitiveness based on the core technologies related to amino acid manufacturing. Its main products include respiratory treatment drugs, high blood pressure treatment drugs, and digestive treatment drugs. The group also manufactures and sells functional cosmetic materials using fusion synthesis, including Jeju natural materials.
Contact
123, Neungheodae-ro 649beon-gil
Namdong-gu
Incheon21697
KORT: +82 327128800
Sector
Basic Materials
Stock type
Cyclical
Industry
Chemicals
Fiscal Year End
31 December 2026
Employees
136
Stocks News & Analysis
stocks
Procter & Gamble earnings: Frigid sales and margins don’t suggest cracks in its standing
North America was a notable blemish, down 2% on an organic basis.
stocks
Our view on Santos after production is ramped up
Barossa at 75% capacity and Pikka undergoing commissioning.
stocks
GE Aerospace earnings: No good deed goes unpunished
We’ve raised our fair value estimate of GE Aerospace stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,196.50 | 22.30 | 0.24% |
| CAC 40 | 8,148.89 | 79.72 | 0.99% |
| DAX 40 | 24,856.47 | 295.49 | 1.20% |
| Dow JONES (US) | 49,384.01 | 306.78 | 0.63% |
| FTSE 100 | 10,150.05 | 11.96 | 0.12% |
| HKSE | 26,757.91 | 127.95 | 0.48% |
| NASDAQ | 23,436.02 | 211.20 | 0.91% |
| Nikkei 225 | 53,870.35 | 181.46 | 0.34% |
| NZX 50 Index | 13,453.51 | 103.36 | -0.76% |
| S&P 500 | 6,913.35 | 37.73 | 0.55% |
| S&P/ASX 200 | 8,865.60 | 20.50 | 0.23% |
| SSE Composite Index | 4,136.66 | 14.09 | 0.34% |